The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has CME Group (CME) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question. CME Group is one of 859 individual stocks in the Finance sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group. The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CME Group is currently sporting a Zacks Rank of #1 (Strong Buy). The Zacks Consensus Estimate for CME's full-year earnings has moved 6.5% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving. Based on the most recent data, CME has returned 12.6% so far this year. In comparison, Finance companies have returned an average of -3.8%. This means that CME Group is outperforming the sector as a whole this year. British Land Company PLC Sponsored ADR (BTLCY) is another Finance stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 4%. For British Land Company PLC Sponsored ADR, the consensus EPS estimate for the current year has increased 1.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Looking more specifically, CME Group belongs to the Securities and Exchanges industry, a group that includes 7 individual stocks and currently sits at #8 in the Zacks Industry Rank. On average, this group has gained an average of 5.3% so far this year, meaning that CME is performing better in terms of year-to-date returns. On the other hand, British Land Company PLC Sponsored ADR belongs to the Real Estate - Operations industry. This 34-stock industry is currently ranked #167. The industry has moved -13.7% year to date. Investors with an interest in Finance stocks should continue to track CME Group and British Land Company PLC Sponsored ADR. These stocks will be looking to continue their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues CME Group Inc. (CME):Free Stock Analysis Report British Land Company PLC Sponsored ADR (BTLCY):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Are Finance Stocks Lagging CME Group (CME) This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...